2nd Annual University of Miami Diabetes Day - Miami Cardio-Reno-Metabolic Conference

1. Understand metabolic physiology and modern classifications/definition of obesity
2. Analyze hormonal and nutrient-based therapies for diabetes and obesity treatment
3. Recognize device benefits and limitations in Type 1 and Type 2 diabetes
4. Review technological features of emerging CGM and CKM sensors and hybrid
5. Recognize device benefits and limitations in Type 1 and Type 2 diabetes
6. Interpret metabolic CGM and/or CKM data to personalize therapy
7. Evaluate therapy options for obesity in T1D and T2D
8. Identify remission pathways in T2D
9. Develop treatment plans considering cardio-renal-metabolic overlap

To register click here.

The University of Miami Leonard M. Miller School of Medicine designates this Live Activity for a maximum of 4.00 of AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Services for the Disabled
If you have needs that require special accommodations, including dietary concerns, please contact the Conference Manager at least 15 days prior to the conference.

For more information, please contact:

Midalys Suarez,MBA

Email: [email protected]

Accessibility Statement
 
University of Miami Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Mitigation of Relevant Financial Relationships

The University of Miami adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Diana Soliman, MD
University of Miami
Miami, FL

Co-Director

Nothing to disclose

Ron T Varghese, MBBS
University of Miami
MIAMI, FL

Co-Director

Nothing to disclose

Rodolfo J Galindo, MD
University of Miami
Miami, FL

Course Director, Faculty

Consulting Fee-Abbott (Any division) (Relationship has ended)|Consulting Fee-Boehringer Ingelheim Pharmaceuticals, Inc. (Relationship has ended)|Consulting Fee-Dexcom (Relationship has ended)|Consulting Fee-Lilly (Any division) (Relationship has ended)|Consulting Fee-Novo Nordisk (Any division) (Relationship has ended)|Consulting Fee-Medtronic (Any division) (Relationship has ended)|Consulting Fee-Bayer (Any division) (Relationship has ended)|Grant or research support-Boehringer Ingelheim Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Novo Nordisk (Any division) (Relationship has ended)

Halis K Akturk, MD
Barbara Davis Center for Diabetes, University of Colorado
aurora, CO

Faculty

Consulting Fee-Dexcom|Consulting Fee-Roche (Any division)|Grant or research support-Abbott (Any division)

Eda Cengiz, MD
Professor
UCSF
San Francisco, CA

Faculty

Advisor-Novo Nordisk (Any division)|Advisor-Lilly (Any division)|Advisor-MannKind|Advisor-Arecor|Advisor-Tandem|Advisor-PortalInsulin (Relationship has ended)|Advisor-Abbott (Any division)

Daniel Drucker, MD
LTRI
Toronto, ON

Faculty

Advisor-Amgen, AstraZeneca Eli Lilly, Insulet, Kallyope, Metsara, Novo Nordisk, Pfizer|Grant or research support-Amgen, Eli Lilly, Zealand

W. Timothy (Tim) Garvey, MD
University Professor
University of Alabama at Birmingham
Birmingham, AL

Faculty

Steven Kahn, MD, Physician
Professsor
VA Puget Sound Health Care System and University of Washington
Seattle, WA

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-AltPep|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Amgen, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Biomea Fusion|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Congruence Therapeutics (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Lilly (Any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-General Medicines|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Roche (Any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Kayothera|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck (Any division)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Neurimmune|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novo Nordisk (Any division)|Grant or research support-Corcept (Relationship has ended)

Leigh Perreault, MD
Professor of Medicine
University of Colorado School of Medicine
Aurora, CO

Faculty

Advisor-Novo Nordisk (Any division)|Advisor-Lilly (Any division)|Advisor-Boehringer Ingelheim Pharmaceuticals, Inc.

Viral N Shah, MD
Professor of Medicine
indiana University School of Medicine
Indianapolis, IN

Faculty

Grant or research support-Dexcom (Relationship has ended)|Grant or research support-Lilly (Any division)|Grant or research support-Alexion Pharmaceuticals|Grant or research support-Zucara Therapeutics|Consulting Fee-Dexcom|Honoraria-Insulet|Consulting Fee-Lilly (Any division)|Consulting Fee-Biomea Fusion (Relationship has ended)|Honoraria-Sequel Med Tech|Consulting Fee-Ascensia Diabetes Care (Relationship has ended)|Advisor-Novo Nordisk (Any division)|Advisor-Sanofi S.A.|Advisor-Tandem |Advisor-Medtronic (Any division)

Jay Skyler, MD
MD, FL

Faculty

Consulting Fee-See attached list

Saturday, November 8, 2025